Common misconceptions

Common mistake
Wrong: PTSD can be diagnosed as soon as symptoms appear after trauma.
Right: PTSD requires symptoms lasting more than 1 month after the traumatic event.
You cannot diagnose PTSD the moment trauma symptoms appear. DSM-5 requires that the symptom cluster persist for more than 1 month after the traumatic event. If symptoms are present but the window is 3 days to 1 month, the correct diagnosis is acute stress disorder. This distinction is clinically meaningful and a favorite exam trap — always check the timeline before committing to PTSD.
Common mistake
Wrong: Benzodiazepines are first-line pharmacotherapy for PTSD.
Right: SSRIs (sertraline, paroxetine) are first-line pharmacotherapy; benzodiazepines are contraindicated in PTSD.
Benzodiazepines feel intuitive for anxiety disorders, but they are contraindicated in PTSD — not just second-line, but actively harmful. They interfere with fear extinction, worsen dissociation, and increase addiction risk in a population already at high risk. The correct first-line pharmacotherapy is an SSRI, specifically sertraline or paroxetine (the only two FDA-approved agents for PTSD). When the stem gives you a PTSD patient and asks for medication, pick an SSRI every time.
Common mistake
Wrong: SSRIs are the targeted agent for trauma-related nightmares and sleep disruption in PTSD.
Right: Prazosin (an alpha-1 blocker) is specifically used to target trauma nightmares and sleep disturbance in PTSD.
SSRIs treat the broad symptom burden of PTSD, but they do not specifically target trauma-related nightmares. Prazosin, an alpha-1 adrenergic receptor blocker, is the agent with evidence for reducing nightmare frequency and improving sleep in PTSD — its mechanism relates to blocking noradrenergic hyperactivity during REM sleep. If the vignette specifically asks about nightmares or sleep disturbance in a PTSD patient who is already on an SSRI, the answer is prazosin.
Common mistake
Wrong: PTSD has three symptom clusters (re-experiencing, avoidance, hyperarousal).
Right: DSM-5 PTSD has four symptom clusters: intrusion, avoidance, negative alterations in cognition/mood, and alterations in arousal/reactivity.
The three-cluster model (re-experiencing, avoidance, hyperarousal) is outdated DSM-IV thinking. DSM-5 split avoidance and added a distinct fourth cluster: negative alterations in cognition and mood. This cluster includes things like persistent negative beliefs, distorted blame, emotional numbing, and anhedonia. Recognizing this matters because exam questions may describe a patient with emotional detachment or guilt and ask which cluster it falls under — the right answer is the cognition/mood cluster, not avoidance.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the four DSM-5 symptom clusters for PTSD: intrusion symptoms, avoidance, negative alterations in cognition and mood, and alterations in arousal and reactivity — and be able to assign a patient's symptoms to the correct cluster.
  2. Distinguish PTSD from acute stress disorder based on symptom duration: acute stress disorder covers 3 days to 1 month post-trauma, while PTSD requires symptoms persisting more than 1 month.
  3. Identify the first-line treatments for PTSD: trauma-focused cognitive behavioral therapy (CBT) is the preferred psychotherapy, and SSRIs (sertraline, paroxetine) are first-line pharmacotherapy — not benzodiazepines, which are contraindicated.
  4. Recognize prazosin as the targeted pharmacologic agent specifically for trauma-related nightmares and sleep disturbance in PTSD, distinct from the general SSRI treatment of core PTSD symptoms.

Can you avoid these mistakes?

A 28-year-old soldier returns from combat 6 weeks ago and has been experiencing flashbacks, avoiding reminders of combat, feeling emotionally numb, and having an exaggerated startle response. He meets full criteria for PTSD. His psychiatrist wants to start a medication. Which agent is first-line pharmacotherapy?
A patient with PTSD is on sertraline but continues to have severe nightmares multiple times per week and reports poor sleep quality. Which additional agent should be considered specifically for this symptom?
A woman involved in a serious car accident 2 weeks ago is experiencing intrusive memories, avoidance of driving, negative mood, and insomnia. She meets full symptom criteria for her diagnosis. What is the correct diagnosis, and why can't you call it PTSD yet?
A medical student lists the DSM-5 symptom clusters for PTSD as: re-experiencing, avoidance, and hyperarousal. What is wrong with this list, and what is the corrected four-cluster framework?

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →